Drapalin 1/17 Maluti CBD is a distinctly indica-dominant hybrid of the cultivars Otto Kush and ACDC with minimal psychoactive properties and a high β-Myrcene content.
The purple hues on the leaves and buds, as well as the grape aroma, give this unique variety the nickname “Grape Cluster.” Its trichomes produce about 15 – 18 % of CBD.
Otto Kush x
THC- / CBD-Content (m/m)
THC ≤1 %
CBD 15,3 % bis 18,7 %
CBD 15,3 % bis 18,7 %
MG Health Limited, Lesotho
Drapalin 24/1 Bafokeng Choice Drapalin 10/11 Batha Balanced Drapalin 18/1 Cheesotho Drapalin 1/17 Maluti CBD
β-Myrcene 64 %
α-Pinene 19 %
β-Caryophyllene 12 %
d-Limonene 5 %
166 – 168 °C
Areas of ApplicationsSince the prescription of medical cannabis flowers to patients is a formulation prescription, the decision on the therapeutic area of application rests with the prescribing physician. Based on the symptoms, medical cannabis is currently most frequently used in Germany for the following diseases:
Anorexia / Cachexia
Lack of appetite
Inflammatory bowel diseases
Tic disorders / Tourette Syndrome
Nausea / Vomiting
Drapalin 1/17 Maluti CBD Product Information
THC ~ 1 % CBD ≤ 17 %
- Muscle relaxant
ReccomendationClinical evidence based on meta-analysis
- Morbus Parkinson
Medication Intake Medicinal cannabis flowers can be taken both through inhalation (e.g. by means of a vaporizer) and orally (e.g. as a tea preparation). The appropriate route of administration should be determined individually by the prescribing physician together with the patient and must be written down on the prescription.
MG Health is about quality and safety MG Health is a well-established medical cannabis manufacturer and our partner in Lesotho. In this landlocked South African country, the medicinal plant is cultivated at an altitude of 2000m in a mountainous environment far away from any industry. These optimal natural conditions, the qualified personnel, and the state-of-the-art facilities guarantee pharmaceutical production at the highest level.
These Products are Distributed in Germany by Drapalin Drapalin Pharmaceuticals GmbH from Munich has been acting as one of the first German importers and wholesalers of medical cannabis since 2018. Their reliable supply of quality products and the active exchange of knowledge with physicians, pharmacists and patient associations establishes their platform for success. You can find all information on current training courses and offers at: www.drapalin.de/fklogin.